Sir Denys Henderson, ICI chairman, yesterday told shareholders that the best protection against a hostile takeover was performance 'helped by cost reductions and strategic positioning'. An extraordinary general meeting approved the demerger and flotation of ICI's Zeneca drugs arm.
(Photograph omitted)
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments